Medi-Caps - MediCaps Share Price

26.75-0.83 (-3.00%)

BSE

Closed
As On:
As On: 19 Jun, 2026, 03:44 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-26.75
Previous Day	-27.58

Medi-Caps Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Medi-Caps Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	9.04	5.06	3.54	3.02	9.10
Total Income Growth (%)	78.62	42.88	17.13	-66.79	117.64
Total Expenses	6.01	5.80	5.36	6.50	7.63
Total Expenses Growth (%)	3.66	8.09	-17.53	-14.78	22.51
EBIT	3.03	-0.74	-1.82	-3.48	1.47
EBIT Growth (%)	-	-	-	-336.16	-
Profit after Tax (PAT)	3.04	-0.77	-1.82	-3.49	1.72
PAT Growth (%)	-	-	-	-303.21	-
EBIT Margin (%)	33.51	-14.58	-51.45	-115.10	16.18
Net Profit Margin (%)	33.67	-15.14	-51.45	-115.53	18.88
Basic EPS (₹)	2.44	-0.61	-1.46	-2.80	1.38

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	0.61	0.95	1.01	0.31	1.16
Total Income Growth (%)	-35.13	-6.27	222.15	-72.99	231.40
Total Expenses	0.94	0.63	0.72	0.71	0.72
Total Expenses Growth (%)	48.77	-12.49	1.69	-1.81	17.76
EBIT	-0.33	0.31	0.29	-0.40	0.44
EBIT Growth (%)	-204.40	9.42	-	-191.17	-
Profit after Tax (PAT)	-0.31	0.29	0.29	-0.40	0.71
PAT Growth (%)	-209.79	-0.52	-	-156.30	-
EBIT Margin (%)	-53.33	33.14	28.39	-126.88	37.59
Net Profit Margin (%)	-50.99	30.13	28.39	-126.88	60.88
Basic EPS (₹)	-0.25	0.23	0.23	-0.32	0.57

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	20.66	28.21	27.82	50.97	71.79
Total Revenue Growth (%)	-26.77	1.39	-45.42	-28.99	21.05
Total Expenses	23.68	29.05	29.07	46.05	61.73
Total Expenses Growth (%)	-18.48	-0.06	-36.89	-25.39	28.43
Profit after Tax (PAT)	-3.04	-0.57	-2.24	1.76	10.08
PAT Growth (%)	-	-	-227.62	-82.58	-9.42
Operating Profit Margin (%)	-24.18	-3.20	-4.55	9.97	14.39
Net Profit Margin (%)	-24.40	-2.24	-8.19	3.55	14.42
Basic EPS (₹)	-2.44	-0.46	-1.80	1.41	8.08

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2.88	2.98	7.31	0.75	0.61
Total Revenue Growth (%)	-3.25	-59.26	880.24	22.82	-
Total Expenses	3.01	2.69	2.49	0.49	0.67
Total Expenses Growth (%)	11.61	8.40	407.00	-26.64	-
Profit after Tax (PAT)	-0.14	0.56	3.89	0.15	-0.04
PAT Growth (%)	-124.99	-85.72	2,554.06	-	-
Operating Profit Margin (%)	-5.40	11.79	67.36	252.26	0.00
Net Profit Margin (%)	-6.01	22.97	54.26	144.47	0.00
Basic EPS (₹)	-0.11	0.45	3.12	0.12	-0.03

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Entering the Green
Company has posted a profit of Rs 3.04 cr in Mar 31, 2026 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 62.21% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	115.46	125.42	127.28	125.99	130.35
Total Assets Growth (%)	-7.94	-1.46	1.03	-3.35	13.53
Total Liabilities	3.85	4.15	6.30	7.42	14.09
Total Liabilities Growth (%)	-7.09	-34.20	-15.02	-47.39	39.46
Total Equity	111.61	121.28	120.98	118.57	116.26
Total Equity Growth (%)	-7.97	0.24	2.03	1.99	11.02
Current Ratio (x)	17.34	17.25	11.41	11.65	5.05
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	-	-	-	2.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	67.34	68.03	68.09	61.63	61.81
Total Assets Growth (%)	-1.01	-0.09	10.48	-0.29	-1.33
Total Liabilities	0.63	0.68	1.60	0.52	0.52
Total Liabilities Growth (%)	-7.35	-57.50	207.69	0.00	-68.86
Total Equity	66.71	67.34	66.49	61.11	61.29
Total Equity Growth (%)	-0.94	1.28	8.80	-0.29	0.52
Current Ratio (x)	92.67	81.66	18.63	194.68	197.81
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	-	-	-	2.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-7.02	5.07	6.94	-6.08	7.02
Net Cash used in Investing Activities	7.11	-4.98	-7.73	-2.56	-4.08
Net Cash flow from Financing Activities	-	-	-	-	-
Net Cash Flow	0.09	0.09	-0.79	-8.64	2.95
Closing Cash & Cash Equivalent	0.50	0.41	0.32	1.11	9.75
Closing Cash & Cash Equivalent Growth (%)	22.11	28.19	-71.14	-88.58	43.26
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-0.47	1.85	3.09	-2.60	-0.95
Net Cash used in Investing Activities	0.42	-1.85	-3.09	1.85	1.01
Net Cash flow from Financing Activities	-	-	-	-	-
Net Cash Flow	-0.05	0.01	0.01	-0.75	0.06
Closing Cash & Cash Equivalent	0.01	0.05	0.05	0.04	0.79
Closing Cash & Cash Equivalent Growth (%)	-86.64	15.42	12.10	-94.85	8.09
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-2.72	-0.47	-1.85	1.48	8.67
Return on Capital Employed (%)	-2.66	-0.66	-1.02	4.07	8.58
Return on Assets (%)	-2.63	-0.45	-1.76	1.39	7.73
Interest Coverage Ratio (x)	-92.48	36.37	0.00	4,166.00	0.00
Asset Turnover Ratio (x)	0.10	0.20	0.22	0.00	-
Price to Earnings (x)	-9.53	-90.91	-24.69	24.88	6.15
Price to Book (x)	0.26	0.43	0.46	0.37	0.53
EV/EBITDA (x)	-23.65	56.94	124.76	6.37	4.39
EBITDA Margin (%)	-9.65	3.54	1.61	13.50	16.99

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-0.20	0.82	5.84	0.23	-0.06
Return on Capital Employed (%)	-0.18	0.42	7.21	0.41	-0.09
Return on Assets (%)	-0.20	0.81	5.71	0.23	-0.06
Interest Coverage Ratio (x)	0.00	0.00	0.00	0.00	0.00
Asset Turnover Ratio (x)	0.03	0.04	0.11	0.00	-
Price to Earnings (x)	-212.77	93.46	14.22	303.03	-1,666.67
Price to Book (x)	0.43	0.77	0.83	0.71	1.01
EV/EBITDA (x)	472.60	116.18	11.07	125.01	1,940.53
EBITDA Margin (%)	2.65	18.41	69.60	343.29	0.00

Insights

Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Medi-Caps Ltd	-10.98	0.30	-2.72	-2.66	-2.63	-25.78	-24.18	-24.40	-2.44	17.34	0.00	0.00
Mangalam Drugs	-1.08	0.46	-43.08	-27.33	-14.09	-14.37	-13.94	-19.12	-28.05	0.79	1.02	25.25
Vista Pharma	-3.81	1.26	-33.09	-39.15	-21.89	58.95	-278.73	-223.37	-1.96	0.92	0.27	-2.27
Sandu Pharma	17.03	0.95	4.04	6.08	3.16	2.31	3.95	2.52	1.83	2.43	0.01	0.07
Roopa Ind	469.00	2.22	0.47	34.75	0.11	18.24	5.86	0.06	2.97	1.25	1.76	6.63
Add More

Annual Ratios (%)

Choose from Peers

Welcure Drugs
Gujarat Terce
Parmax Pharma
Rekvina Labs
Zenlabs Ethica

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Medi-Caps Ltd Stock Performance	-3.00	-5.61	-13.37	13.25	-37.86	-33.34	-40.75
Mangalam Drugs Stock Performance	0.39	0.30	5.26	-5.92	-61.56	-72.01	-77.84
Vista Pharma Stock Performance	-0.79	2.90	3.76	-1.58	-32.73	-14.84	-39.20
Sandu Pharma Stock Performance	1.30	15.00	12.26	16.41	-24.85	-23.63	5.87
Roopa Ind Stock Performance	-1.29	-9.61	-9.83	11.65	-16.54	13.96	231.66
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	64,05,044	51.36 %	0.60
Pledge	0	0.00 %	0.00
DII	900	0.01 %	0.00
MF	900	0.01 %	0.00
Others	60,64,012	48.64 %	-0.60

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	51.36	50.76	50.77	50.77
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.01	0.01
Mutual Funds	0.00	0.00	0.01	0.01
Others	48.64	49.24	49.22	49.22

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 14, 2026
Board Meeting
Quarterly Results
Feb 04, 2026
Board Meeting
Quarterly Results
Nov 04, 2025

Board Meetings

Announced on	Meeting on
May 14, 2026	May 21, 2026
Audited Results
Feb 04, 2026	Feb 11, 2026
Quarterly Results
Nov 04, 2025	Nov 12, 2025
Quarterly Results
Jul 28, 2025	Aug 05, 2025
Quarterly Results
May 14, 2025	May 21, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
Aug 13, 2012 Sep 20, 2012 15%
Sep 02, 2011 Sep 22, 2011 15%
Aug 27, 2010 Sep 22, 2010 15%
Aug 05, 2009 Sep 24, 2009 15%
Aug 01, 2008 Sep 24, 2008 15%
Bonus
Announced on Ex-Date
Feb 07, 2013 Mar 19, 2013
Bonus Ratio: 3 share(s) for every 1 shares held
Splits
No Data Available

Announced on	Ex-Date	Dividend%
Aug 13, 2012	Sep 20, 2012	15%
Sep 02, 2011	Sep 22, 2011	15%
Aug 27, 2010	Sep 22, 2010	15%
Aug 05, 2009	Sep 24, 2009	15%
Aug 01, 2008	Sep 24, 2008	15%

Announced on	Ex-Date
Feb 07, 2013	Mar 19, 2013
Bonus Ratio: 3 share(s) for every 1 shares held

Rights

Announced on	Ex-Date
Jan 20, 1995	Feb 03, 1995
Rights ratio: 1 share for every 5 held at a price of Rs 126.0
Sep 29, 1992	Jul 24, 1992
Rights ratio: 1 share for every 2 held at a price of Rs 10.0
Sep 30, 1991	-
Rights ratio: 2 share for every 5 held at a price of Rs 10.0

AGM/EGM Meetings

Announced on	Meeting on
Aug 26, 2025	Sep 18, 2025
-
Aug 07, 2024	Sep 26, 2024
Book closure from Sep 20, 2024 to Sep 26, 2024
Sep 12, 2023	Sep 29, 2023
A.G.M.
Aug 12, 2021	Sep 28, 2021
Book closure from Sep 22, 2021 to Sep 28, 2021
Aug 12, 2021	-
Book closure from Sep 22, 2021 to Sep 28, 2021

About Medi-Caps

MediCaps Ltd., incorporated in the year 1983, is a Small Cap company (having a market cap of Rs 33.36 Crore) operating in Pharmaceuticals sector.

MediCaps Ltd. key Products/Revenue Segments include Income From Real Estate Development and Lease Rentals for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 9.04 Crore, up 78.62 % from last quarter Total Income of Rs 5.06 Crore and down .73 % from last year same quarter Total Income of Rs 9.10 Crore. Company has reported net profit after tax of Rs 3.04 Crore in latest quarter.

The company’s top management includes Mr.Ramesh Chandra Mittal, Mr.Alok K Garg, Mrs.Kusum Mittal, Mr.Ashok Omprakash Agrawal, Mr.Dharmendra Solanki, Mr.Gajendra Singh, Mr.Hemant Sethi, Mr.Abhishek Jain. Company has Rawka & Associates as its auditors. As on 31-03-2026, the company has a total of 1.25 Crore shares outstanding.

Medi-Caps Ltd Share Price Today is Rs. 26.75. On previous day, the Medi-Caps Ltd Share Price (NSE) closed at Rs. 27.58, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 51.36% of the stake in Medi-Caps Ltd shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Medi-Caps Ltd stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.01% as compared to 0.01% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Medi-Caps Ltd shares 0.01% was held by mutual funds. The rest including public held is 0.0%. Medi-Caps Ltd stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Medi-Caps Ltd Dividend: Ever since 1983, Medi-Caps Ltd dividends has been paid out around 10 times. As on 19 Jun, 2026, 03:44 PM IST, The overall dividend yield for Medi-Caps Ltd stands at 0.0%. The last dividend paid was on September 20, 2012 (Rs. 1.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -2.44.

Medi-Caps Ltd Bonus: The most recent bonus issue had been in year March 19, 2013 around 13 years ago at 1 : 3 ratio. The first bonus issue was announced in Feb 2013.

Stock Forecast:
After showing 9.04 Cr. of sales and 0.0% of quarterly net null, there have been multiple ups and downs in the Medi-Caps Ltd stock prices in the past few weeks. For example, Medi-Caps Ltd stock price on 12th of June 2026 was around Rs. 26.92. Medi-Caps Ltd share price now stands at an average of Rs. 26.75. Judging by last week's performance, stock is in up trend.

Medi-Caps Ltd has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Medi-Caps Ltd share.

Historical Prices and Performance:
Medi-Caps Ltd, incorporated in 1983 is a Small Cap company (with a market cap of Rs. 33.36) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Medi-Caps Ltd stock was -2.72%, -0.47%, -1.85%, 1.48% and 8.67% respectively.
The Medi-Caps Ltd share gave a 3 year return of -27.31% as compared to Nifty 50 which gave a return of 28.03%.
Medi-Caps Ltd announced 15.0% final dividend on September 20, 2012.

Key Metrics:
PE Ratio of Medi-Caps Ltd is -11.35
Prices/Sales Ratio of Medi-Caps Ltd is 2.32
Price/Book Ratio of Medi-Caps Ltd is 0.31

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Medi-Caps Ltd, major competitors and peers include Alpa Labs, Krebs Biochem, Bal Pharma and Par Drugs & Chemical. As of Dec 2025, the dividend yield of Medi-Caps Ltd stands at 0.0% while Alpa Labs, Krebs Biochem, Bal Pharma and Par Drugs & Chemical stand at 0.0%, 0.0%, 1.38% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -11.35 and 0.31 respectively.

Leadership of Medi-Caps Ltd :
Abhishek Jain is Co. Secretary & Compl. Officer
Hemant Sethi is Chief Financial Officer
Gajendra Singh is Ind. Non-Executive Director
Ramesh Chandra Mittal is Chairman & Non-Exe.Director
Alok K Garg is Managing Director
Kusum Mittal is Non Executive Woman Director
Dharmendra Solanki is Ind. Non-Executive Director
Ashok Omprakash Agrawal is Ind. Non-Executive Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

201, Pushpratna Paradise,9/5, New Palasia,Indore, Madhya Pradesh - 452001

Contact

investors@medicaps.com

http://www.medicaps.com

PE Ratio(x)	-10.98
EPS - TTM(₹)	-2.44
MCap(₹ Cr.)	33.36
MCap Rank	160
PB Ratio(x)	0.31
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	46.99
52W Low(₹)	21.00
MCap/Sales	2.32
Beta(1 Month)	-0.29
BV/Share(₹)	89.50

1 Day	-3.0%
1 Month	-1.26%
3 Months	7.0%
1 Year	-38.89%
3 Years	-27.31%
5 Years	-41.66%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Medi-Caps - MediCaps Share Price

Key Metrics

Medi-Caps Ltd share price insights

Medi-Caps Ltd Share Price Returns

Medi-Caps Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Medi-Caps Ltd Top Searches

Corporate Actions

About Medi-Caps

Executive Leadership

Auditors

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News